Enhancing evidence-based care using trial emulation in electronic health records: real-world effects of empagliflozin in people with type 2 diabetes.

Saved in:
Bibliographic Details
Title: Enhancing evidence-based care using trial emulation in electronic health records: real-world effects of empagliflozin in people with type 2 diabetes.
Authors: Ryan DK; Institute of Health Informatics, University College London, London, UK smgxdry@ucl.ac.uk., Keogh RH; Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK., Williamson E; Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK., Lumbers RT; Institute of Health Informatics, UCL, London, UK., Diaz-Ordaz K; Department of Statistical Science, University College London, London, England, UK., Shah AD; Institute of Health Informatics, University College London, London, UK., Bidulka P; Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Source: BMJ open diabetes research & care [BMJ Open Diabetes Res Care] 2026 Feb 09; Vol. 14 (1). Date of Electronic Publication: 2026 Feb 09.
Publication Type: Journal Article
Journal Info: Publisher: Published by BMJ in partnership with the American Diabetes Association Country of Publication: England NLM ID: 101641391 Publication Model: Electronic Cited Medium: Internet ISSN: 2052-4897 (Electronic) Linking ISSN: 20524897 NLM ISO Abbreviation: BMJ Open Diabetes Res Care Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2052-4897
DOI:10.1136/bmjdrc-2025-005672